Teva's 'Strategic Decision' On FCA Testimony Gets Judge's Ire
A New York federal judge on Tuesday said that Teva Pharmaceuticals made a "strategic decision" not to challenge expert testimony in a False Claims Act case and that she has "no...To view the full article, register now.
Already a subscriber? Click here to view full article